$HURN

Truist raises Huron Consulting stock price target on growth outlook

Truist Securities raised its price target on Huron Consulting Group (HURN) to $220 from $175, maintaining a Buy rating. The firm expects 10-12% revenue growth in 2027, exceeding consensus estimates. HURN's shares have gained 10.6% in the past week and 58.7% over six months. The company reported stronger-than-expected Q2 2026 results, with adjusted earnings of $2.46 per share and revenue of $465.6 million, and raised its full-year outlook.

Original reporting
Published Oct 23, 2026, 10:24 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 10:29 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$HURN
Bullish
high confidence
Mentioned
$HURN
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HURNBullishMed
01

Why it matters

The upgrade could trigger short‑term buying and set a higher valuation baseline.

02

Market read

Analyst target raise is a fresh catalyst for HURN, likely prompting price movement.

03

What to watch

Potential regulatory changes in healthcare could affect long‑term margins.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Truist upgraded Huron Consulting after its Q2 2026 earnings beat and raised full‑year outlook.

Company-level read

Ticker impact

$HURNBullishHigh confidence
Context

Truist Securities raised its price target on Huron Consulting Group to $220, citing stronger growth outlook and recent earnings beat.

Expected impact

upward pressure as investors price in higher growth expectations

Evidence & confidence

The new $220 target is above the current price and follows a beat of Q2 2026 earnings, suggesting fresh buying interest.

Market effects

Positive outlook for consulting firms serving healthcare and education may lift peers.

U.S. market may see modest gains in professional services sector.

Limited to U.S. listed consulting stocks.

Counterpoint

Target raise may be premature if macro‑economic headwinds slow digital spending.

Key entities

  • Truist Securities

    Equity research firm issuing the target raise.

  • Huron Consulting Group

    Consulting firm focused on healthcare and education.

Related articles

$HURNMedAI 8/10

5 Insightful Analyst Questions From Huron’s Q2 Earnings Call

Huron reported Q2 CY2026 revenue of $475M vs $460.4M estimates, and adjusted EPS of $2.46 vs $2.17, with adjusted EBITDA of $72.64M. The company raised full-year guidance to $1.87B revenue and $9.20 adjusted EPS midpoint. Management attributed growth to AI-enabled solutions and managed services expansion, including outcome-based contracts.

$HURNMedAI 8/10

Huron Consulting Group Inc. Q2 2026 Earnings Call Summary

Strategic Performance Drivers Achieved record RBR growth of 16% driven by strong organic performance across all three segments and a meaningful step-up in digital capabilities. Healthcare segment growth of 17% was fueled by persistent financial challenges for providers, including rising labor and supply costs that outpace reimbursements.

$HURNHighAI 9/10

Why Is Huron (HURN) Stock Soaring Today

Huron Consulting Group (HURN) shares rose 35.8% after the company reported Q2 results that beat analyst expectations and lifted its full-year outlook. Revenue was $475M, up 15.4% YoY versus $449M consensus. Adjusted EPS was $2.46 versus $2.17 forecast. Huron raised full-year revenue guidance to $1.87B midpoint and adjusted EPS to $9.20.

$HURNHighAI 9/10

Huron Consulting Group Shares Soar 32% After Blowout Earnings Beat and Raised Full-Year Guidance Today

Huron Consulting Group (Huron) shares rose 32.11% to $160.34 after the firm reported Q2 adjusted EPS of $2.46 vs $2.17 expected and revenue of $475.0 million vs about $449 million expected. Huron raised 2026 guidance to revenue before reimbursable expenses of $1.85B-$1.89B and adjusted EPS of $9.00-$9.40, citing AI work and acquisitions including RelateCare.